» Articles » PMID: 12006649

Utrophin Binds Laterally Along Actin Filaments and Can Couple Costameric Actin with Sarcolemma when Overexpressed in Dystrophin-deficient Muscle

Overview
Journal Mol Biol Cell
Date 2002 May 15
PMID 12006649
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Dystrophin is widely thought to mechanically link the cortical cytoskeleton with the muscle sarcolemma. Although the dystrophin homolog utrophin can functionally compensate for dystrophin in mice, recent studies question whether utrophin can bind laterally along actin filaments and anchor filaments to the sarcolemma. Herein, we have expressed full-length recombinant utrophin and show that the purified protein is fully soluble with a native molecular weight and molecular dimensions indicative of monomers. We demonstrate that like dystrophin, utrophin can form an extensive lateral association with actin filaments and protect actin filaments from depolymerization in vitro. However, utrophin binds laterally along actin filaments through contribution of acidic spectrin-like repeats rather than the cluster of basic repeats used by dystrophin. We also show that the defective linkage between costameric actin filaments and the sarcolemma in dystrophin-deficient mdx muscle is rescued by overexpression of utrophin. Our results demonstrate that utrophin and dystrophin are functionally interchangeable actin binding proteins, but that the molecular epitopes important for filament binding differ between the two proteins. More generally, our results raise the possibility that spectrin-like repeats may enable some members of the plakin family of cytolinkers to laterally bind and stabilize actin filaments.

Citing Articles

Evolution and developmental functions of the dystrophin-associated protein complex: beyond the idea of a muscle-specific cell adhesion complex.

Mirouse V Front Cell Dev Biol. 2023; 11:1182524.

PMID: 37384252 PMC: 10293626. DOI: 10.3389/fcell.2023.1182524.


Dystrophin involvement in peripheral circadian SRF signalling.

Betts C, Jagannath A, van Westering T, Bowerman M, Banerjee S, Meng J Life Sci Alliance. 2021; 4(10).

PMID: 34389686 PMC: 8363758. DOI: 10.26508/lsa.202101014.


Ixazomib, an oral proteasome inhibitor, exhibits potential effect in dystrophin-deficient mdx mice.

Micheletto M, Hermes T, Bertassoli B, Petri G, Perez M, Fonseca F Int J Exp Pathol. 2020; 102(1):11-21.

PMID: 33296126 PMC: 7839951. DOI: 10.1111/iep.12383.


Variable cytoplasmic actin expression impacts the sensitivity of different dystrophin-deficient mdx skeletal muscles to eccentric contraction.

Lindsay A, Southern W, McCourt P, Larson A, Hodges J, Lowe D FEBS J. 2019; 286(13):2562-2576.

PMID: 30942954 PMC: 6613979. DOI: 10.1111/febs.14831.


Protein disulfide isomerase as a prosurvival factor in cell therapy for muscular and vascular diseases.

Di Rocco G, Baldari S, Gentile A, Capogrossi M, Toietta G Stem Cell Res Ther. 2018; 9(1):250.

PMID: 30257707 PMC: 6158916. DOI: 10.1186/s13287-018-0986-y.


References
1.
Kramarcy N, Vidal A, Froehner S, Sealock R . Association of utrophin and multiple dystrophin short forms with the mammalian M(r) 58,000 dystrophin-associated protein (syntrophin). J Biol Chem. 1994; 269(4):2870-6. View

2.
Tinsley J, Deconinck N, Fisher R, Kahn D, Phelps S, Gillis J . Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med. 1998; 4(12):1441-4. DOI: 10.1038/4033. View

3.
Peters M, Adams M, Froehner S . Differential association of syntrophin pairs with the dystrophin complex. J Cell Biol. 1997; 138(1):81-93. PMC: 2139947. DOI: 10.1083/jcb.138.1.81. View

4.
Phelps S, Hauser M, COLE N, Rafael J, Hinkle R, Faulkner J . Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. Hum Mol Genet. 1995; 4(8):1251-8. DOI: 10.1093/hmg/4.8.1251. View

5.
Pons F, Augier N, Heilig R, Leger J, Mornet D, Leger J . Isolated dystrophin molecules as seen by electron microscopy. Proc Natl Acad Sci U S A. 1990; 87(20):7851-5. PMC: 54848. DOI: 10.1073/pnas.87.20.7851. View